$SBFM News

Sunshine Biopharma Receives Canada Approval For Its Generic Rivaroxaban Tablets

Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today

Sunshine Biopharma Stock Rallies On Canadian Approval For Generic Amoxicillin

Sunshine Biopharma Announces Approval Of Generic Amoxicillin Formulation For Canadian Market

Why Is Sunshine Biopharma Stock Falling Tuesday?

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering

Sunshine Biopharma Prices $6M Public Offering Of 12M Units At A Price Of $0.50 Per Share Or Pre-Funded Warrant And 2 Series C Warrants

Sunshine Biopharma Will Be Issued U.S. Patent Number 12,624,066 Tomorrow Titled "INHIBITORS OF CORONAVIRUS PROTEASE (AND USES OF THE COMPOUNDS FOR THE TREATMENT OR PREVENTION OF VIRAL INFECTION)".

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

Sunshine Biopharma's Nora Pharma Gains Canadian FDA-Equivalent Clearance For Domperidone Used In Chemotherapy-Induced Nausea

Sunshine Biopharma's Nora Pharma Gains Canadian FDA-Equivalent Clearance For Domperidone Used In Chemotherapy-Induced Nausea

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

Sunshine Biopharma Announces Commercial Launch Of Generic Doxycycline In Canada

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Sunshine Biopharma Stock Is Surging Thursday: Here's What's Happening

Sunshine Biopharma shares are trading higher after the company announced its subsidiary, Nora Pharma, launched Pravastatin.

Sunshine Biopharma Canadian Subsidiary, Nora Pharma, Launches Pravastatin, Generic Prescription Drug In Therapeutic Class Of Lipid Metabolism Regulators

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)